熱門資訊> 正文
MediWound获得欧洲创新委员会1，625万欧元融资
2024-07-16 21:46
MediWound (NASDAQ:MDWD) said on Tuesday it has been selected to receive €16.25M in blended funding from the European Innovation Council through its accelerator program.
Shares of the company are up about 1.2% in early trade.
The funding will significantly advance the company’s EscharEx development program for patients with diabetic foot ulcers, MDWD said.
Pending FDA and EMA approval, the funding will enable the Company to expedite the market introduction of this biologic by four years, ahead of MediWound’s original schedule.
The funding package includes a €2.5 million grant and an investment, with terms to be finalized between the company and the EIC, MediWound said in a statement.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
